In conclusion, we have identified several differences, such as Th1 and Tc1 dominance and the association between CXCR3+ (Th1 and Tc1) and disease activity in T cell subsets on PBL, in MS patients compared with HC, but these differences did not appear in NMO patients. This evidence concerns the gene CXCR3 and myeloid sarcoma.